全文获取类型
收费全文 | 259184篇 |
免费 | 17906篇 |
国内免费 | 238篇 |
专业分类
耳鼻咽喉 | 2464篇 |
儿科学 | 6526篇 |
妇产科学 | 7256篇 |
基础医学 | 32270篇 |
口腔科学 | 5186篇 |
临床医学 | 26055篇 |
内科学 | 53387篇 |
皮肤病学 | 5190篇 |
神经病学 | 26575篇 |
特种医学 | 11025篇 |
外国民族医学 | 1篇 |
外科学 | 39219篇 |
综合类 | 1224篇 |
现状与发展 | 2篇 |
一般理论 | 129篇 |
预防医学 | 20608篇 |
眼科学 | 9435篇 |
药学 | 14422篇 |
2篇 | |
中国医学 | 301篇 |
肿瘤学 | 16051篇 |
出版年
2023年 | 5586篇 |
2022年 | 6373篇 |
2021年 | 8949篇 |
2020年 | 9120篇 |
2019年 | 6323篇 |
2018年 | 6476篇 |
2017年 | 6277篇 |
2016年 | 6272篇 |
2015年 | 6717篇 |
2014年 | 12294篇 |
2013年 | 12143篇 |
2012年 | 10752篇 |
2011年 | 10730篇 |
2010年 | 9892篇 |
2009年 | 9116篇 |
2008年 | 9693篇 |
2007年 | 9724篇 |
2006年 | 9468篇 |
2005年 | 8734篇 |
2004年 | 8149篇 |
2003年 | 8030篇 |
2002年 | 8015篇 |
2001年 | 7578篇 |
2000年 | 7944篇 |
1999年 | 7354篇 |
1998年 | 2750篇 |
1997年 | 2339篇 |
1996年 | 2435篇 |
1995年 | 2224篇 |
1994年 | 1866篇 |
1993年 | 1615篇 |
1992年 | 5843篇 |
1991年 | 5752篇 |
1990年 | 5840篇 |
1989年 | 5479篇 |
1988年 | 5204篇 |
1987年 | 2285篇 |
1985年 | 1556篇 |
1984年 | 1833篇 |
1983年 | 1431篇 |
1982年 | 1540篇 |
1981年 | 1440篇 |
1980年 | 1351篇 |
1979年 | 1429篇 |
1978年 | 1277篇 |
1977年 | 1096篇 |
1976年 | 1059篇 |
1975年 | 916篇 |
1974年 | 1156篇 |
1973年 | 995篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2022,24(8):1252-1260
BackgroundThe clinical importance of postoperative hyperamylasemia (POHA) grade is unknown. Our objectives were to evaluate the association of POHA grade with clinically relevant postoperative pancreatic fistula (CR-POPF) and compare its prognostic utility against postoperative day 1 drain fluid amylase (DFA-1).MethodsPatients who underwent pancreatectomy from January 2019 through March 2020 were identified in the ACS NSQIP pancreatectomy-targeted dataset. POHA grade was assigned using post-operative serum amylase and clinical sequelae. The primary outcome was CR-POPF within 30 days. The association of POHA grade with CR-POPF was assessed using multivariable logistic regression, and c-statistics were used to compare POHA grade versus DFA-1.ResultsPOHA occurred in 520 patients at 98 hospitals, including 261 (50.2%) with grade A, 234 (45.0%) with grade B, and 25 (4.8%) with grade C POHA. CR-POPFs were increased among patients with grade B (66.2%, OR 9.28 [5.84–14.73]) and C (68.0%, OR 10.50 [3.77–29.26]) versus grade A POHA (19.2%). POHA-inclusive models better predicted CR-POPF than those with DFA-1 alone (p < 0.002) and models with both predictors outperformed POHA alone (p = 0.039).ConclusionPOHA grade represents a measure of post-pancreatectomy outcomes that predicts CR-POPF and outperforms DFA-1 but must be aligned with new international definitions. 相似文献
12.
13.
14.
15.
16.
17.
18.
19.
《Clinical lung cancer》2022,23(7):e443-e452
IntroductionHispanics living in the United States have higher rates of Epidermal Growth Factor Receptor (EGFR) mutations compared with Non-Hispanic Whites. While this higher incidence is like Asian patients living in the United States, the outcomes for Hispanic patients differ. We looked to compare the variances in mutational profiles between Hispanics and Asians in Los Angeles.Patients and MethodsThree hundred ninety three non-small cell lung cancer (NSCLC) patients treated at Los Angeles County + University of Southern California (LAC + USC) Medical Center and Norris Comprehensive Cancer Center who received comprehensive genomic profiling (CGP) were evaluated from July 2017 to August 2020. CGP was done using tissue biopsies (n = 211) from Caris Life Sciences and liquid biopsies (n = 231) from Guardant Health. Multivariate logistic regression evaluated the role of race between Hispanics and Asians.ResultsIn the Hispanic cohort (n = 90), 50.0% were male, median age of diagnosis was 62, 54.5% were non-smokers, and 85.5% had adenocarcinoma. In Asians (n = 142), 47.5% were male, median age of diagnosis was 65, 59.6% were non-smokers, and 83.8% had adenocarcinoma. Hispanic patients had greater prevalence of Kirsten rat sarcoma virus (KRAS) mutations (odds ratio [OR] 4.42, 95% confidence interval [95% CI]: 1.63-12.83) and lesser prevalence of EGFR mutations (OR 0.31, 95% CI: 0.16-0.59). There were a greater proportion of Hispanic smokers with KRAS mutations (14/41; 34.1%) than Asian smokers (4/58; 6.9%).ConclusionWe saw a greater percentage of Hispanics with KRAS mutations despite similar smoking percentages along with a greater percentage of Asians with EGFR mutations. This study shows that ethnic and racial backgrounds of the patient can influence the effects of potentially carcinogenic exposures leading to variances of mutation frequency of NSCLC among different ethnicities. 相似文献
20.